Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (4771)	7/11/1998 7:28:00 PM
From: Dauntless	Read Replies (2) \| Respond to of 7041

Brad - thanks for your thoughts - Of course, many will ignore them as you are only an M.D. More to the point, the continued attacks on just about everything concerning Zonagen & Vasomax simply point out how desperate the shorts are over the recent stock action. Some have been shorting the stock from the low 30's down to the low teens. It's now at 25 and rising so it looks like most of those are in trouble. One or two M.D.'s have posted negative opinions, an equal number have been positive. First, the FDA, and then the market will decide. Most comments regarding Vasomax sales to date in Mexico, favorable or not, simply reveal how little the posters actually know and understand about marketing and the medical industry. Can anyone detail the following?: The timetable for the formal marketing program in Mexico? When did it start? How many salesmen are pushing Vasomax vs. Viagra? What are the marketing expenditures to date? How are they targeted? Are the programs complete? What are the countrywide results for efficacy, side effects? What do the MExican MD's think of Vasomax vs. Viagra? And on, and on, and on........ If you didn't think of these questions then you're not qualified to comment on the Mexican results. If you are aware of these questions and presented information based on a "survey" of, at best, a handful of pharmacies - then you are dishonest. Of course, that's not real news about some posters on this thread, is it? The first "official" data on the Mexican market & Vasomax will probably not be revealed until the next quarterly report. Until the, you're just blowing smoke up your own skirts.

To: Brander who wrote (4771)	7/11/1998 11:10:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

<<Concerning the patent, I believe that they do have a legitimate patent for their product. It was not purchased with cheap stock.>> Incorrect on both counts. The first patent covers various delivery methods for phentolamine (e.g. transmucosal). The patent actually downplays oral administration. For months, Zonagen shills tried to spin this patent by claiming that Vasomax would be placed under the tounge. The patent was indeed paid for with stock (I'm not sure if additional cash was involved.). The second patent was owned by a former Zonagen emplyee and only covers a certain mixture of inert ingredients and a disintegrant - the so-called "fast acting" formulation. Problem is that oral phentolamine is hardly "fast acting". Shills tried to spin this one as well. <<Also, the clinical trial suggest that Zonagen is helpful in treating ED>> Bullsh*t.